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Objectives. The objective was to investigate whether a treatment with a needle stimulation pad (NSP) changes perceived pain and/or
sensory thresholds in patients with chronic neck (NP) and lower back pain (BP). Methods. 40 patients with chronic NP and 42
patients with chronic BP were equally randomized to either treatment or waiting list control group. The treatment group self-
administered a NSP over a period of 14 days. Pain ratings were recorded on numerical rating scales (NRSs). Mechanical detection
thresholds (MDTs) and pressure pain thresholds (PPTs) were determined at the site of maximal pain and in the adjacent region,
vibration detection thresholds (VDT) were measured at close spinal processes. The Northwick Park Neck Pain Questionnaire
(NPQ) and the Oswestry Disability Index (ODI) were utilized for the NP and BP study, respectively. Results. NRS ratings were
significantly reduced for the treatment groups compared to the control groups (NP: P = .021 and BP: P < .001), accompanied by
a significant increase of PPT at pain maximum (NP: P = .032 and BP: P = .013). There was no eﬀect on VDT and MDT. The NPQ
showed also a significant improvement, but not the ODI. Conclusions. The mechanical NSP seems to be an eﬀective treatment
method for chronic NP and BP.
1. Introduction
Chronic pain syndromes aﬀecting the neck and lower back
are very common and thus clinically relevant [1–7]: the
lifetime prevalence for neck pain (NP) is approximately 48–
66% and for lower back pain (BP) 51–84%. Of these patients,
9–18% suﬀer from severe chronic NP and 15–37% from
severe chronic BP [1–4, 6–9].
Both syndromes therefore have already a high socioeco-
nomic relevance and the incidence is still increasing. It is
estimated that the total costs of low-back pain in the USA
exceed 100 billion US $ per year, including the direct costs
for treatment and the indirect costs for work absenteeism
[10, 11]. The total costs of neck pain in The Netherlands in
1996 were estimated to be 686 million US $ [12].
Chronic pain syndromes of the back such as lumbago
and/or neck pain are essentially characterised by muscle pain
and thus relate to deep somatic pain. Like visceral pain, deep
somatic pain is dull, diﬃcult to localize (for an overview see
[13]), and diﬃcult to treat.
2 Evidence-Based Complementary and Alternative Medicine
Furthermore, the complaints can be very obstinate.
Therefore, treatment remains challenging. The underlying
cause is often not easily detected, as there is a mismatch
between the patient′s complaints and suﬀering and the
“objective” diagnostic results (e.g., MPI, CT, clinical exam-
ination) [14–16]. This particular clinical situation is com-
monly referred to as “chronic pain disorder” and requires a
special approach to treatment.
Since BP and NP are usually of deep somatic origin, it
seems reasonable that, in order to treat these pain syndromes,
naturopathic therapists often apply methods that specifically
deform and manipulate somatic body structures, such
as subcutaneous tissue, skeletal musculature, and fascias.
Consequently, the American National Centre for Comple-
mentary and Alternative Medicine subsumes these therapies
under the superordinate concept of “Manipulative and Body-
Based Practices” (http://nccam.nih.gov/health/whatiscam).
Well-known examples of such treatments are, for exam-
ple, massages, cupping, and the rhythmic massage of anthro-
posophic medicine [17]. Until now there is limited evidence
that manual therapies can be eﬀective treatment for chronic
BP and NP [18, 19], nonetheless CAM receives increasing
attention in the treatment of both chronic pain conditions
[20–22].
One self-administered device used for the treatment
of NP and BP is the needle stimulation pad (NSP). The
NSP—with more than 1000 sharp, but nonpenetrating
plastic needles, is usually placed on soft ground and the
patient lies for a limited time period on top of the mat
with the uncovered, painful part of the body. It is very
popular in some countries (Scandinavia) and is distributed
under numerous names [23–25]. Those devices all have
in common that they contain a flexible material, mostly
cloth or soft plastic. On this pad sharp plastic spikes are
aﬃxed. There is a resemblance to the well-known bed of
nails of indian sadhus or wise men. In the 1980s, a modern
version was reinvented in Russia to serve as a kind of self-
acupuncture device [23, 25]. Since then, multiple pads are
widely used either as a tool for well-being or as a medical
device. Indications include pain disorders, especially pain
of the lower back, neck and headache, but also sleeping
disorders, diseases of the gastrointestinal tract or just for
relaxation [23, 25]. Mostly the pad is applied directly at
the painful area, but some pads are bigger in size and are
used underneath the lying whole body. These mats are often
used for relaxation. The NSP is mostly self-administered
without the survey of a therapist, therefore little is known
about the diﬀerent practices of application. Furthermore, the
treatment outcome of the NSP and the mechanisms of action
remain unclear. However, due to the intense mechanical
stimulation of the skin, the subcutaneous tissue, and muscles
induced by the needle stimulation, it can be speculated that
its mode of action is similar to other complementary and
alternative medicine (CAM) manual and physical therapies,
namely, via direct mechanical stimulation of the skin and
the subcutaneous tissue [26, 27]. The NSP likely activates
skin mechanoreceptors and even nociceptors, a process that
might aﬀect the transmission and processing of sensory
information to the spinal and supraspinal level [27].
A recent study investigating the eﬀect of a NSP in
healthy young volunteers showed substantial eﬀects on car-
diac autonomic responses and reactions of the sympathetic
and parasympathetic nervous system, such as self-rated
relaxation, blood pressure, heart rate, heart rate variability,
and back temperature [25]. In contrast to the data presented
here, the pad was bigger in size and covered a larger area of
the back.
Quantitative sensory testing (QST) is a well-established
procedure and is predominantly used for the analysis of
the somatosensory phenotype of patients suﬀering from
neuropathic pain [28, 29]. However, subtests of the test
battery, especially the pressure pain threshold (PPT), have
been utilized as outcome measures in treatment studies on
chronic pain [30–41].
The aim of the two present pilot studies was to investigate
whether a two-week treatment period using the NSP changes
the pain levels of participants with chronic NP and lower
BP. Furthermore, possible treatment eﬀects on mechani-
cal sensory thresholds, in particular mechanical detection
(MDT), pressure pain (PPT), and vibration detection (VDT)
thresholds were investigated. The whole QST-protocol would
have consumed up to an hour per location, so that the entire
protocol was considered to be too time consuming for a pilot
study. Therefore, these particular QST subtests were chosen
for pragmatic reasons, because they are indicative for the two
diﬀerent pathways, which can be considered to play a role.
VDT and MDT are indicative for the lemniscal and PPT for
the spinothalamic pathway (for review see [42–44]).
2. Methods
2.1. Participants. Inclusion criteria were age between 18
and 75 and nonspecific NP or lower BP for at least three
consecutive months. The patients were excluded if they
reported radicular pain, showed neurological symptoms
suggesting a disc prolapse, had a vertebral column surgery
less than 12 months prior to the study, a chiropractic
manoeuvre or infiltration at the area treated 4 weeks prior
to the inclusion in the study, or a congenital deformation
of the spine. Further exclusion criteria were an insulin-
dependent diabetes mellitus, dermatological diseases or
skin changes at the treated area, severe mental illness that
required medication, a known tendency for haemorrhages,
current anticoagulation, or corticosteroid medication. Pain
medication with the exception of corticosteroids as well as
physiotherapy were allowed, if the treatment regimen was
not altered for four weeks prior to the study and continued
throughout the study. Other related physical or manual
therapies like acupuncture, cupping, TENS were not allowed.
Participants were recruited using flyers, by announcement
through the homepage of the Chair of Complementary and
Integrative Medicine, Kliniken Essen-Mitte, Germany, and
through a local newspaper article. Study applicants were
screened twice, first by a standardized telephone interview
and second by the study physician, who examined the patient
at their first appointment. This “on site” assessment during
the first visit was performed to ensure patient safety. All
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inclusion and exclusion criteria were checked again, a careful
patient history was taken, and a thorough physical examina-
tion, including neurological examination, was performed to
rule out a clinical suspected spinal alteration, for example,
discus prolapse. All participants provided written informed
consent before participating in the study.
2.2. Study Design. The study was planned and conducted
in compliance with the Declaration of Helsinki (World
Medical Association) and the Guidelines for good clinical
practice. The protocols were approved by the institutional
review board of the University of Duisburg-Essen Medical
Institutions, Germany (no. 08-3767 for BP and 08-3768
for NP). Both studies were carried out independently but
according to a similar protocol. They were conducted as
two-week open randomized controlled pilot trials at the
Department of Complementary and Integrative Medicine
Kliniken Essen-Mitte, Essen, Germany from October 2008 to
May 2009.
At the first examination, a medical history was collected
and each participant was thoroughly examined. Subjective
assessments on pain and function were taken, and sensory
thresholds were determined. Subsequently the participants
were randomly assigned to a home-based treatment either
(TG) or waiting list control group (WL). The participants in
the TG were thoroughly instructed how to use the NSP. All
patients were asked to document medication and physiother-
apy treatments in a treatment diary. Fourteen days later the
evaluation of NRS ratings, the questionnaire and the sensory
examination were repeated for both groups. After the second
examination day, patients of the WL received the NSP.
2.3. Treatment Allocation. In order to rigorously ensure that
at the time of enrolment, medical examination, and baseline
measurement the group allocation was unknown to every-
body involved in the study, randomization was performed
after completion of the first (baseline) measurement. The
randomization procedure itself was performed as a lottery,
without stratification or sequencing. The “lottery tickets”
consisted of the exact number of “treatment” or “con-
trol” tickets needed, hidden in sealed, nonmarked opaque
envelopes. These envelopes were prepared before the enrol-
ment started and kept in a “lottery box”. The envelopes were
manually shuﬄed before each draw and the patients picked
an envelope after the completion of the first measurement.
2.4. Intervention. The treatment consisted of a home-based,
self-administered intervention with the mechanical NSP (see
Figure 1).
It is a medical device, which has been applied for years
by patients with diverse pain syndromes. Diﬀerent versions
of this pad are available in various sizes. The same NSP was
used in both studies: a 22 × 33 cm plastic mat featuring 60
hexagonic plastic discs. On each of these discs, 19 spikes are
aﬃxed with the distance between the 1140 spikes being 5mm
(Zhencidian pad, CMP Chinese Medical Products Trading
GmbH, Austria).
Figure 1: Needle stimulation pad.
Participants were instructed to apply the NSP over a
period of 14 days once daily according to the following
procedure: in a first step, the patients were instructed to press
both hands (only NP study) or both feet (only BP study) for
10 minutes on the mat while sitting on a chair. The protocol
is to treat the hands of patients with neck pain and feet of
patients with lower back pain, respectively, prior to the actual
painful area derived from clinical experience. The protocol
represents the way the NSP is applied in our clinic. It was
recommended to place the NSP afterwards on a soft base,
for example, the bed and to lie on top of the mat with the
uncovered painful part of the body (neck or lower back,
resp.). The patients were also instructed to place a towel or
a bedroll underneath the neck, if the neck was to be treated.
The participants were informed that the first 2 to 5 minutes
could be painful. A daily treatment time of about 30 minutes
was recommended for the painful part of the body.
2.5. Subjective Measures. A numerical rating scale (NRS)
ranging from 0 = no pain to 10 = worst pain imaginable was
used [45, 46]. Furthermore, the Oswestry Disability Index
(ODI), which measures the disability of patients with lower
BP, was utilized [47–49]. The ODI score ranges from 0 to 100.
A modified Northwick Park Neck Pain Questionnaire (NPQ)
(which is scored out of 32 or 28 for noncar drivers and is
presented as a percentage) was used to assess the severity of
chronic NP. The NPQ score ranges from 0 to 100, with higher
scores indicating higher pain and lower function [50].
2.5.1. Mechanical Sensitivity to Superficial versus Deep Stim-
uli. Sensory testing was performed in a quiet room with
constant room temperature (approx. 82–84◦F) and air
humidity (approx. 75%) and included the MDT, PPT, and
VDT according to the quantitative sensory testing protocol
[28, 29]. In order to eliminate test-retest bias due to diﬀerent
assessors, only one assessor was assigned to each of the
studies. Both assessors were thoroughly trained to perform
the procedure.
All sensory tests were conducted at the point of maxi-
mum pain and 10 cm caudal paraspinal (for NP patients) or
10 cm cranial paraspinal (for lower BP patients), respectively.
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Furthermore, sensory tests were conducted at two control
sites apart from the painful area, the right hand, and foot,
serving as measures of intraobserver reliability.
2.5.2. Mechanical Detection Threshold (MDT). MDT was
tested with a standardized set of von-Frey-filaments (The
SenseLab Aesthesiometer, Somedic, Sweden). Von-Frey-
filaments are nylon filaments with a rounded tip; aﬃxed
in a rectangular manner at a handlebar. They are pressed
perpendicularly with constant force onto the skin surface
(paravertebral, hand dorsum, and foot dorsum) until the
filament bends. Using the method of limits, a psychophysical
method to approximate thresholds, five threshold determi-
nations were made, each with a series of ascending and
descending stimulus intensities. The test always started with
a von Frey filament that was clearly sensed by the test
person. In the next step, the examiner took the next smaller
filament. This procedure was repeated until the test person
was unable to sense a filament. Then this particular filament
was annotated as the first subliminal stimulus. Now the
test was continued in ascending order, and the next bigger
filament was taken again until the test person could feel a
filament. This is the next value above the threshold. The final
threshold is represented by the geometric mean of these 10
values.
2.6. The Final Threshold Was the Geometric Mean of
These Five Series
2.6.1. Pressure Pain Threshold (PPT). PPTwas determined by
means of an algometer (Somedic, Sweden) with a probe area
of 1 cm2 using three series of ascending stimulus intensities
(slowly increasing ramp of ∼20 kPa/s) at a muscular area
(paravertebral muscles, thenar eminence and foot dorsum
over the musculus extensor hallucis brevis). The patient was
instructed to press a button, as soon as this pressure was
perceived as being painful. The final threshold was the
arithmetic mean out of all 3 measurements.
2.6.2. Vibration Detection Threshold (VDT). VDT was mea-
sured with a Rydel Seiﬀer tuning fork (64Hz, 8/8 scale)
which was placed over a bony prominence (processus
spinosus, processus styloideus ulnae, and malleolus inter-
nus). After the tuning fork has been induced into vibrations
it was placed over the tested area. The tested person was
asked, if he sensed the vibration and should indicate, if the
vibration had stopped. The particular value was read out of
the 8/8 scale and the final threshold was the arithmetic mean
out of 3 subsequent descending measurements.
The control group was oﬀered the same NSP postinter-
vention.
3. Data Analysis
These trials were pilot trials not only designed to explore
the eﬀectiveness of the NSP but moreover to generate
hypotheses about the potential mechanisms of action. Thus,
only patients giving a complete set of data were analysed per
protocol, and missing values were not imputed.
According to the Quantitative Sensory Testing (QST)-
protocol [28, 29] PPT and MDT data were transformed
logarithmically before statistical analysis, VDT data were
analysed as raw data. NPQ and ODI scores were calculated
and expressed as percentages (ranging from 0 to 100).
Each outcome parameter was analysed by a univariate
analysis of covariance, modelling treatment as a fixed factor,
and the respective baseline value as a covariate. Diﬀerences
between treatment groups were tested by two-sided t-tests
within these models. All analyses were conducted with the
SAS statistical software (release 8.2, SAS Institute, Cary NC,
USA). P values < .05 were regarded as statistically significant.
4. Results
Forty patients were included in the NP and 42 patients were
included in the BP study (see flow charts Figures 2 and 3).
Of the participants recruited for the NP-study 3 partic-
ipants were lost to followup due to reasons not related to
the study. Moreover, 2 participants, both from the control
group, violated the treatment protocol. One began a TENS
treatment during the study and the other was hospitalized
with severe NP and shoulder pain and received repeated
acupuncture treatments. Of the 42 patients recruited for
the BP-study, nobody was lost to followup or violated the
protocol. Most patients in both studies were females, the
average age was 46.1 (±11.3) years in the in the NP study
and 63.9 (±11.1) years in the BP study (Table 1).
While there were no baseline diﬀerences in the BP study,
baseline diﬀerence for NRS ratings and NPQ scores occurred
in the NP study (Table 2).
Moreover, gender was not equally distributed across
groups: 85% of the patients in the treatment group were
females compared to 100% in the control group (Table 1).
4.1. Pain and Disability. In both studies, treatment reduced
the NRS pain ratings significantly compared to the control.
In the NP study, the estimated group diﬀerence was d =
−1.6 pts; with 95%-CI: −2.8 to −.3 (P = .021) and in the BP
study it was d = −2.3 pts with 95%-CI: −3.2 to −1.3 (P <
.001) (Figure 4, Table 2).
NP-induced disability was significantly improved after
treatment compared to the control group by d = −7.4 NPQ
score points (95%-CI: −13.7 to −1.1, P = .028) (Figure 5,
Table 2), while there was no group eﬀect in the BP study
(diﬀerence in the ODI score: d = .4; 95%-CI: −4.8 to 5.6, P =
.878) (Figure 5, Table 2).
4.2. Mechanical Pain and Detection Thresholds. Test-retest
correlations in the control areas (hands and feet) were high
and statistically significant, indicating good reliability and
accuracy (see Table 3).
A significant group diﬀerence was seen for NP (d =
.106; CI: .013 to .198, P = .032) and BP (d = .082; CI: .021
to .144, P = .013) for log PPT at the point of maximum
pain (Figure 6, Table 2), while at 10 cm distance from pain






   
   













Excluded (n = 18)
Did not meet inclusion criteria (n = 2)
Refused to participate (n = 17)
Lost to followup (n = 0)
Violation of protocol (n = 2)
(1 used TENS,
1 received acupuncture treatment)
Analyzed (n = 18)
Excluded from analysis (n = 0)
Analyzed (n = 17)
Excluded from analysis (n = 0)
Lost to followup (n = 3)
(1 adverse weather conditions,
2 did not keep the appointment)
Allocated to treatment group
(Acupressure pad = AP) (n = 20)
Received AP (n = 20)






Other reasons (n = 0)
Randomized (n = 40)
Assessed for eligibility (n = 59)
Allocated to waiting list control (n = 20)
Figure 2: Consort E-flowchart: neck pain study.
Table 1: Baseline characteristics.
NP study BP study
Treatment group Control group Treatment group Control group
N 17 18 21 21
Percentage female (%) 82.4 100 71.4 66.7
Mean (SD) age (years) 47.0 (10.9) 48.0 (12.1) 63.1 (11.9) 64.5 (10.6)
maximum this was the case for BP only (d = .076; CI: .006 to
.139, P = .038).
There was, however, a tendency for greater pain threshold
to pressure-induced pain at 10 cm distance from maximum
pain in the NP study (d = 0.85; CI: −.002 to .171, P = .064)
(Figure 7, Table 2).
No statistically significant eﬀects between patients and
controls were seen for PPT at the control areas, as well as for
MDT and VDT in general (Table 2).
4.3. Adverse Eﬀects. Besides the discomfort or pain when
lying on the pad, especially at the first minutes of the first
sessions, no adverse eﬀects of the mechanical NSP were
reported.
5. Discussion
The outcome of the two studies presented here further
supports the usefulness of the NSP as a representative of
naturopathic therapies in the treatment of chronic pain
syndromes.
To our knowledge, the two studies are the first to system-
atically investigate the outcome of the NSP as a therapeutic
agent in two highly prevalent chronic pain syndromes. The
results show that the NSP significantly reduced pain ratings
in patients suﬀering from chronic pain of the neck or the
lower back. Pre- to posttreatment decreases in the NRS of
30% in the NP study and 36% in the BP study are in the range
of a moderately important clinical diﬀerence [51, 52]. The
eﬀect was robust and stable even after a comparatively short
treatment period (as daily treatments for 2 weeks). At least in
NP, as shown in the NPQ, the treatment improved physical
functioning and thus reduced the NP-related disability. Why
the ODI was slightly worse than at baseline remains unclear.
Chronification of pain may originate at the level of the
nociceptor, the spinal cord, or the brain (e.g., [17, 26]).
Although these mechanisms cannot be separated in a chronic
pain condition, diﬀerent treatment strategies may have their
focus on diﬀerent levels of the pain process.












Analyzed (n = 21)
Excluded from analysis (n = 0)
Analyzed (n = 21)
Excluded from analysis (n = 0)
Lost to followup (n = 0) Lost to followup (n = 0)
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Randomized (n = 42)
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Figure 3: Consort E-flowchart: back pain study.
It is assumed that hyperalgesia is associated with the
hyperexcitability of central neurons in the spinal cord
[53, 54]. As hypersensitivity is caused by peripheral and
central sensitization [55, 56] these changes are by far not
static but build the matrix of the dynamic receptive field
plasticity [57]. The peripheral sensitization is thought to be
mediated by an axon reflex, which sensitizes the receptors.
Central sensitization occurs with a long lasting enlargement
of receptive fields and recruitment of silent nociceptors.
The threshold for aﬀerent stimuli is decreased, caused by
permanent neuroplastic changes in the spinal cord [57].
These mechanisms are hypothesized to be involved in the
development of a chronic pain disorder even when the
initial injury or inflammation is no longer present [58]. The
presence of widespread sensory hypersensitivity is linked to
central hypersensitivity, augmented central pain processing
[59], or decreased descending control of pain [60].
Naturopathic treatments that induce controlled but
clearly visible injuries of the skin, such as, for example, gua
sha massage or wet cupping, markedly alter the nociceptor
environment. It can be assumed that these injuries, which
are often clearly visible for several days, lead to increase
firing of the nociceptive fibres in the aﬀected regions [61].
Such an increased firing for several hours up to days
may directly influence the receptive fields of spinal neurons
in the aﬀected region. If this is the case, these treatments
are likely to induce specific, demonstrable eﬀects on the
somatocutaneous or viscerosomatic projection areas. Such
eﬀects can be demonstrated by measuring the patients’ pain
thresholds. (For a comprehensive test battery on sensory
testing, see the QST-protocol [28, 29]). Interestingly enough,
pressure pain thresholds were increased at the point of
maximum pain in both studies, reflecting that treatment has
at least locally (peripherally) reduced hyperalgesia to blunt
pressure in both syndromes. In the BP study, reduction of
deep pain sensitivity was also present remote from the most
painful area. These findings suggest that part of the treatment
eﬀect seems to be due to changes of nociceptive processing in
the spinothalamic tract as well as at the level of the central
nervous system.
Because there were no relevant diﬀerences in VDT
and MDT, a possible involvement of the lemniscal tract is
not likely. Larger studies including a nontreatment control
group, a healthy control group, and including further QST-
tests as well as the assessment of both body sides will reveal
more conclusive evidence for the pathway in question.
Previous studies in which various forms of cupping ther-
apy, for example, dry cupping [40], wet cupping [38], and
pulsating cupping [39] have been examined with QST in
patients with neck pain showed similar results: improvement
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Table 2: Pre- to posttreatment changes (mean and standard deviation) and estimated group diﬀerences (from analysis of covariance) of
outcome parameters. Bold values indicate significant P values.
Control group Needle stimulus pad Estimated diﬀerence
(95% CL) PPre Post Pre Post
Pain (Numeric Rating Scale)
Neck pain 4.4 (1.8) 4.5 (2.2) 4.9 (2.0) 3.4 (2.7) −1.6 (−2.8 to − 0.3) 0.021
Lower back pain 4.9 (1.9) 5.4 (1.9) 5.0 (2.3) 3.2 (2.2) −2.3 (−3.2 to − 1.3) <0.001
Function (Neck Pain Questionnaire NPQ or Oswestry Disease Index ODI)
Neck pain 33.2 (11.1) 32.5 (9.2) 36.3 (13.5) 26.5 (15.7) −7.4 (−13.7 to − 1.1) 0.028
Lower back pain 25.0 (13.9) 19.9 (10.9) 22.8 (14.5) 18.8 (14.6) 0.4 (−4.8 to 5.6) 0.878
Log pressure pain threshold (PPT) area of maximum pain
Neck pain 2.303 (0.168) 2.311 (0.182) 2.193 (0.221) 2.314 (0.264) 0.106 (0.013 to 0.198) 0.032
Lower back pain 2.548 (0.186) 2.534 (0.170) 2.552 (0.150) 2.619 (0.110) 0.082 (0.021 to 0.144) 0.013
Log pressure pain threshold (PPT) 10 cm close to maximum pain
Neck pain 2.358 (0.173) 2.319 (0.142) 2.331 (0.202) 2.380 (0.264) 0.085 (−0.002 to 0.171) 0.064
Lower back pain 2.588 (0.178) 2.534 (0.170) 2.570 (0.138) 2.596 (0.109) 0.073 (0.006 to 0.139) 0.038
Log mechanical detection threshold (MDT) area of maximum pain
Neck pain 0.118 (0.316) 0.174 (0.369) 0.129 (0.480) 0.132 (0.347) −0.043 (−0.282 to 0.196) 0.726
Lower back pain 0.477 (0.598) 0.342 (0.526) 0.423 (0.375) 0.486 (0.413) 0.174 (−0.062 to 0.409) 0.156
Log mechanical detection threshold (MDT) 10 cm close to maximum pain
Neck pain −0.067 (0.410) −0.080 (0.427) 0.128 (0.488) −0.040 (0.422) −0.049 (−0.306 to 0.208) 0.712
Lower back pain 0.563 (0.491) 0.376 (0.499) 0.317 (0.435) 0.359 (0.449) 0.145 (−0.085 to 0.376) 0.224
Vibration detection threshold (VDT) area of maximum pain
Neck pain 6.7 (1.4) 6.7 (0.9) 6.3 (1.3) 6.1 (1.5) −0.4 (−1.1 to 0.3) 0.247
Lower back pain 3.8 (2.0) 4.1 (1.7) 4.2 (1.7) 4.2 (1.9) −0.2 (−1.0 to 0.5) 0.514
Vibration detection threshold (VDT) 10 cm close to maximum pain
Neck pain 6.5 (1.0) 6.5 (1.1) 6.0 (1.4) 5.7 (1.5) −0.5 (−1.1 to 0.2) 0.165
Lower back pain 5.1 (1.1) 5.0 (1.3) 5.0 (1.6) 5.0 (1.2) 0.1 (−0.5 to 0.7) 0.774
Table 3: Spearman correlation coeﬃcients for detections thresholds in control areas.
Neck pain Lower back pain
Hand Foot Hand Foot
PPT 0.833 (P < 0.001) 0.690 (P < .001) 0.601 (P < .001) 0.590 (P < 0.001)
MDT 0.752 (P < 0.001) 0.568 (P < .001) 0.686 (P < .001) 0.632 (P < 0.001)
VDT 0.541 (P = 0.001) 0.645 (P < .001) 0.420 (P = .006) 0.740 (P < 0.001)
in pain ratings, increased PPT, and no eﬀect in VDT and
MDT. These results may suggest that the NSP and the various
cupping therapies act in a similar way.
The often reported deep relaxation induced by many
of the manipulative and body-based therapies contributes
to well-being and thus works through the aﬀective-
motivational component of pain [62] and probably adds to
the overall treatment eﬀect.
There are several limitations in these studies. While
there were no baseline diﬀerences and no drop outs in
the BP study, a critical factor for the interpretation of the
results of the NP study is the apparent baseline diﬀerence
for NRS ratings, NPQ scores, QST-scores, and gender in
the NP study. However, the analysis of covariance with the
respective baseline value as a covariate controls in part for
this diﬀerence. Moreover, the high percentage of female
participants in both studies exceeds the gender-specific back
or neck pain prevalences [9] likely suggesting that more
female than male patients are interested in CAM treatments
[63], therefore, the generalisability of the results to a male
patient population is limited.
The waiting list control strategy may be considered
a potential weakness of the study. However, there is no
valid inactive sham control for the needle stimulation pad
available to date. Even the blunting of the sharp needle tips
would still induce a rather strong mechanical stimulation.
8 Evidence-Based Complementary and Alternative Medicine
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Figure 4: Numerical rating scale (mean ± SEM) of patients
with chronic neck pain and chronic lower back pain at baseline
(pretreatment) and after 2 weeks (posttreatment). Patients in the
neck pain treatment group (filled circle) as well as in the lower
back pain treatment group (filled square) showed a significant
treatment eﬀect compared to the controls (open symbols). P values
are indicated as ∗P < .05, ∗∗∗P < .001.
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controltreatment

























Figure 5: Scores of the Northwick Park Neck Pain Questionnaire
(NPQ) and Oswestry Disability Index (ODI) (mean ± SEM) of
patients with chronic neck pain and chronic lower back pain at
baseline (pretreatment) and after 2 weeks (posttreatment). Patients
of the neck pain treatment group (filled circle) had significantly
lower neck-pain-related disabilities after 2 week treatment com-
pared to patients in the waiting list control (open circle). No such
eﬀect could be detected in the ODI in lower back pain patients
(filled square = treatment group, open square = control group). P
values are indicated as ∗P < .05, n. s. (no significance).
Therefore, a waiting list control seemed to be the best
way to control for the eﬀect of anticipation or for being
included into a study. Furthermore, the waiting list control
groups in these two studies are rather reflecting “standard
treatment” since all patients were allowed to stay on their
current treatment strategies, be it medication or physio-
therapy, except for those treatments, which were among
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controltreatment
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Figure 6: Pressure pain thresholds (mean ± SEM) at the area of
maximum pain of patients with 413 chronic neck pain and chronic
lower back pain at baseline (pretreatment) and after 2 weeks 414
(posttreatment). Patients in the neck pain treatment group (filled
circle) as well as in the 415 lower back pain treatment group (filled
square) showed a significant treatment eﬀect 416 compared to
controls (open symbols). P values are indicated as ∗P < .05.
Pre- Post- Pre- Post-
controltreatment
Pre- Post- Pre- Post-
controltreatment
Neck pain Lower back pain
n. s.
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Figure 7: Pressure pain thresholds (mean± SEM) at the area 10 cm
close to maximum pain of patients with chronic neck pain and
chronic lower back pain at baseline (pretreatment) and after 2 weeks
(posttreatment). Only patients in the lower back pain treatment
group (filled square) had a significant treatment eﬀect compared to
patients in the control group (open square). No significant eﬀect
could be found in the neck pain group (filled circle = treatment
group, open circle = control group). P values are indicated as ∗P
< .05, n. s. (no significance).
the exclusion criteria. Considering the fact that in clinical
trials of conservative treatments for chronic nonspecific NP,
changes in pain scores are generally similar between waiting-
list control and placebo control groups [64], and the fact,
that the sensory threshold measurements are not easy to
see through for the study participants, we feel confident
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that the described treatment eﬀects are valid. However, there
are no good sham protocols for most these procedures
available, although attempts to construct such controls
are very innovative [65]. Blinding remains an issue to be
debated on and furthermore, it was recently argued that,
for example, sham acupuncture is associated with large
unspecific eﬀects [66]. This probably also accounts for any
sham procedure for most of these interventions. Future
clinical trials with a definite character should therefore
compare diﬀerent therapies with regard to their comparative
eﬀectiveness.
In the two pilot studies presented here, a rather short-
treatment protocol with defined treatment units was applied.
However, in clinical practice, patients apply the pad typically
whenever they feel intense pain and that may be several
times a day. Until now no data are available, which treatment
duration and frequency reveal the best therapeutic results.
Because these studies were pilot studies, we used a pragmatic
approach and did not change a protocol that derived from
clinical experience, which means that participants pressed
their hands (NP study) or their feet (BP study) in advance
of the painful area. It is not clear if this protocol influences
the outcome, but this question could be included in further
trials. Nonetheless, it is doubtful that there is an exact dose-
eﬀect relationship, but more likely that there is an individual
“optimal dose”.
6. Conclusion
The needle stimulation pad revealed a substantial potential
for the alleviation of chronic NP and BP. Furthermore,
psychophysical data support the assumption that the pad
reveals its eﬀects at least partly on a subcortical level of the
pain processing system. A further benefit of the device is the
fact that it is easy to use, safe, and does not require a therapist.
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